Lamivudine [clinicaltrials_resource:84bc89e9bcc3d7649690e2405b015ae0]
Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy [clinicaltrials:NCT00000831]A Phase I Study of Methotrexate for HIV Infection [clinicaltrials:NCT00000834]Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine [clinicaltrials:NCT00000838]A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months [clinicaltrials:NCT00000841]The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children [clinicaltrials:NCT00000865]A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone [clinicaltrials:NCT00000870]Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection [clinicaltrials:NCT00000872]Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection [clinicaltrials:NCT00000875]A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000878]Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects [clinicaltrials:NCT00000882]Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 [clinicaltrials:NCT00000885]A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000887]Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies [clinicaltrials:NCT00000888]Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315 [clinicaltrials:NCT00000891]A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients [clinicaltrials:NCT00000899]Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children [clinicaltrials:NCT00000901]A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment [clinicaltrials:NCT00000902]A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood [clinicaltrials:NCT00000916]A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure [clinicaltrials:NCT00000918]A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [clinicaltrials:NCT00000919]Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns [clinicaltrials:NCT00000920]A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART) [clinicaltrials:NCT00000922]Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328 [clinicaltrials:NCT00000923]Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV [clinicaltrials:NCT00000940]A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants [clinicaltrials:NCT00000944]A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children [clinicaltrials:NCT00000952]A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children [clinicaltrials:NCT00001066]The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs [clinicaltrials:NCT00001067]A Study of Disease Progression and Anti-HIV Treatments [clinicaltrials:NCT00001068]The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients [clinicaltrials:NCT00001075]Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals [clinicaltrials:NCT00001080]Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001083]A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients [clinicaltrials:NCT00001084]A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients [clinicaltrials:NCT00001085]The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs [clinicaltrials:NCT00001087]Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens [clinicaltrials:NCT00001091]A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir [clinicaltrials:NCT00001095]A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses [clinicaltrials:NCT00001108]Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV [clinicaltrials:NCT00001119]Lamivudine for Chronic Hepatitis B [clinicaltrials:NCT00001457]
intervention [clinicaltrials_vocabulary:intervention]
Lamivudine [clinicaltrials_resource:84bc89e9bcc3d7649690e2405b015ae0]
Bio2RDF identifier
84bc89e9bcc3d7649690e2405b015ae0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:84bc89e9bcc3d7649690e2405b015ae0
intervention name [clinicaltrials_vocabulary:intervention-name]
Lamivudine
identifier
clinicaltrials_resource:84bc89e9bcc3d7649690e2405b015ae0
title
Lamivudine
@en
type
label
Lamivudine [clinicaltrials_resource:84bc89e9bcc3d7649690e2405b015ae0]
@en